"Macula Lutea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
Descriptor ID |
D008266
|
MeSH Number(s) |
A09.371.729.522
|
Concept/Terms |
Macula Lutea- Macula Lutea
- Lutea, Macula
- Luteas, Macula
- Macula Luteas
|
Below are MeSH descriptors whose meaning is more general than "Macula Lutea".
Below are MeSH descriptors whose meaning is more specific than "Macula Lutea".
This graph shows the total number of publications written about "Macula Lutea" by people in this website by year, and whether "Macula Lutea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2014 | 1 | 1 | 2 |
2015 | 2 | 0 | 2 |
2016 | 3 | 0 | 3 |
2017 | 1 | 3 | 4 |
2018 | 6 | 0 | 6 |
2019 | 1 | 1 | 2 |
2020 | 5 | 1 | 6 |
2021 | 4 | 0 | 4 |
2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macula Lutea" by people in Profiles.
-
Total retinal thickness: a neglected factor in the evaluation of inner retinal thickness. BMJ Open Ophthalmol. 2022 09; 7(1).
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022 02 19; 399(10326):741-755.
-
Acute Macular Neuroretinopathy Secondary to Rickettsia typhi Infection. J Neuroophthalmol. 2023 09 01; 43(3):e67-e69.
-
Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study. Ophthalmol Retina. 2022 03; 6(3):219-227.
-
Paracentral Acute Middle Maculopathy in Pregnancy. J Neuroophthalmol. 2022 03 01; 42(1):e440-e442.
-
Diagnostic and Therapeutic Challenge. Retina. 2021 Jul 01; 41(7):1570-1576.
-
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration. Ophthalmology. 2021 07; 128(7):1027-1038.
-
Automated vessel density detection in fluorescein angiography images correlates with vision in proliferative diabetic retinopathy. PLoS One. 2020; 15(9):e0238958.
-
Aqueous Cytokine Expression and Higher Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study. Am J Ophthalmol. 2021 02; 222:328-339.
-
Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study. Ophthalmol Retina. 2021 01; 5(1):60-70.